CNE100003PG4
CNE100003PG4
PHARMARON
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 14.095.078.735 | 12.275.774.875 | 14.8% |
| Cost of Revenue | 9.185.448.199 | 8.072.643.718 | 13.8% |
| Gross Profit | 4.909.630.536 | 4.203.131.157 | 16.8% |
| 2.684.905.009 | 2.338.755.546 | 14.8% | |
| Operating Income | 2.224.725.527 | 1.864.375.610 | 19.3% |
| Pretax Income | 1.912.710.459 | 2.091.263.494 | 8.5% |
| Net Income Common Stockholders | 1.663.898.879 | 1.793.350.815 | 7.2% |
| -- | -- | -- | |
| -- | -- | -- |